Total Payments
$800,700
2024 Payments
$163,060
Companies
43
Transactions
2,337
Medicare Patients
5,254
Medicare Billing
$419,942
Payment Breakdown by Category
Other$668,445 (83.5%)
Consulting$72,060 (9.0%)
Food & Beverage$40,520 (5.1%)
Travel$17,157 (2.1%)
Research$2,000 (0.2%)
Education$518.73 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $668,445 | 288 | 83.5% |
| Consulting Fee | $72,060 | 45 | 9.0% |
| Food and Beverage | $40,520 | 1,750 | 5.1% |
| Travel and Lodging | $17,157 | 236 | 2.1% |
| Unspecified | $2,000 | 1 | 0.2% |
| Education | $518.73 | 17 | 0.1% |
Payments by Type
General
$798,700
2,336 transactions
Research
$2,000
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $183,185 | 498 | $0 (2024) |
| PFIZER INC. | $180,241 | 273 | $0 (2024) |
| Amgen Inc. | $86,548 | 127 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $76,075 | 117 | $0 (2024) |
| GENZYME CORPORATION | $53,630 | 82 | $0 (2024) |
| Celgene Corporation | $49,357 | 94 | $0 (2019) |
| Incyte Corporation | $44,196 | 84 | $0 (2024) |
| UCB, Inc. | $38,271 | 100 | $0 (2024) |
| STRATA Skin Sciences, Inc. | $29,607 | 33 | $0 (2024) |
| Allergan, Inc. | $13,482 | 20 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $163,060 | 410 | UCB, Inc. ($29,085) |
| 2023 | $126,017 | 377 | Amgen Inc. ($22,662) |
| 2022 | $129,328 | 331 | PFIZER INC. ($25,816) |
| 2021 | $86,270 | 231 | Amgen Inc. ($23,749) |
| 2020 | $53,283 | 125 | AbbVie Inc. ($19,039) |
| 2019 | $86,738 | 270 | AbbVie, Inc. ($39,695) |
| 2018 | $74,896 | 293 | PFIZER INC. ($37,550) |
| 2017 | $81,108 | 300 | Celgene Corporation ($27,584) |
All Payment Transactions
2,337 individual payment records from CMS Open Payments — Page 1 of 94
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Incyte Corporation | OPZELURA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Dermatology | ||||||
| 12/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $36.18 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $9.38 | General |
| 12/20/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $4.69 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,208.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.37 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Travel and Lodging | Cash or cash equivalent | $89.78 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $12.75 | General |
| 12/13/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $1.34 | General |
| Category: Inflammation & Immunology | ||||||
| 12/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $5.41 | General |
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Immunology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.17 | General |
| Category: Immunology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,909.00 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Immunology | ||||||
| 12/09/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Inflammation & Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Incyte Corporation | OPZELURA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $128.00 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,458 | 2,513 | $271,425 | $119,425 |
| 2022 | 17 | 1,224 | 1,981 | $218,885 | $98,079 |
| 2021 | 19 | 1,456 | 2,387 | $231,504 | $121,298 |
| 2020 | 15 | 1,116 | 1,856 | $165,601 | $81,140 |
Total Patients
5,254
Total Services
8,737
Medicare Billing
$419,942
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 247 | $42,060 | $21,084 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 271 | 339 | $44,070 | $19,845 | 45.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 180 | 224 | $35,840 | $17,316 | 48.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 208 | 255 | $30,600 | $9,283 | 30.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 40 | 43 | $17,200 | $8,677 | 50.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 41 | 58 | $12,760 | $7,109 | 55.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $17,040 | $6,596 | 38.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 149 | 907 | $9,070 | $4,438 | 48.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $8,850 | $3,864 | 43.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 60 | 64 | $8,960 | $3,684 | 41.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $6,160 | $3,669 | 59.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 27 | 34 | $10,880 | $3,256 | 29.9% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 19 | 23 | $4,140 | $2,084 | 50.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 42 | 50 | $5,500 | $1,921 | 34.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 16 | 17 | $3,060 | $1,559 | 50.9% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 22 | $5,060 | $1,361 | 26.9% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 12 | 12 | $4,500 | $1,310 | 29.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 25 | 25 | $3,000 | $1,128 | 37.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 11 | 25 | $2,000 | $952.46 | 47.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 27 | $675.00 | $286.78 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 245 | $41,650 | $20,115 | 48.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 233 | 280 | $36,420 | $16,569 | 45.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 138 | 170 | $27,200 | $13,277 | 48.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 40 | 40 | $16,000 | $8,439 | 52.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 164 | 199 | $23,880 | $7,257 | 30.4% |
About Michael Nazareth, M.D./PH.D
Michael Nazareth, M.D./PH.D is a Dermatology healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1467614172.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Nazareth, M.D./PH.D has received a total of $800,700 in payments from pharmaceutical and medical device companies, with $163,060 received in 2024. These payments were reported across 2,337 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($668,445).
As a Medicare-enrolled provider, Nazareth has provided services to 5,254 Medicare beneficiaries, totaling 8,737 services with total Medicare billing of $419,942. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Williamsville, NY
- Active Since 06/25/2008
- Last Updated 06/25/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1467614172
Products in Payments
- Otezla (Drug) $132,484
- DUPIXENT (Biological) $103,858
- EUCRISA (Drug) $91,176
- SKYRIZI (Biological) $68,761
- OPZELURA (Drug) $44,196
- Humira (Biological) $43,884
- CIBINQO (Drug) $42,363
- Bimzelx (Biological) $31,126
- XTRAC (Device) $29,549
- LITFULO (Drug) $24,397
- RINVOQ (Biological) $15,700
- Skyrizi (Biological) $14,138
- Sotyktu (Drug) $10,905
- HUMIRA (Biological) $6,527
- Zoryve (Drug) $6,452
- ORACEA (Drug) $4,505
- DUPIXENT (Drug) $4,390
- SOOLANTRA (Drug) $3,819
- Otezla (Biological) $3,371
- EPIDUO FORTE (Drug) $2,867
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Williamsville
Dr. Robert Kalb, Md, MD
Dermatology — Payments: $150,681
Dermatology $150,681
David Altman, M.d, M.D
Dermatology — Payments: $23,899
Dermatology $23,899
Dr. Animesh Sinha, M.d, M.D
Dermatology — Payments: $10,537
Dermatology $10,537
Zoey Glick, M.d. As Of 5/17/09, M.D. AS OF 5/17/09
Dermatology — Payments: $8,249
Dermatology $8,249
Tara Paolini, Md, MD
Dermatology — Payments: $7,501
Dermatology $7,501
Melissa Sicurella
Dermatology — Payments: $3,686
Dermatology $3,686